UBS Group’s Apexigen, Inc. Common Stock APGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,376
| Closed | -$2.13K | – | 8907 |
|
|
2023
Q1 | $2.13K | Sell |
4,376
-5,657
| -56% | -$2.76K | ﹤0.01% | 7472 |
|
|
2022
Q4 | $6.82K | Buy |
10,033
+2,071
| +26% | +$1.41K | ﹤0.01% | 7786 |
|
|
2022
Q3 | $22K | Buy |
7,962
+4,614
| +138% | +$12.7K | ﹤0.01% | 6201 |
|
|
2022
Q2 | $34K | Sell |
3,348
-1,275
| -28% | -$12.9K | ﹤0.01% | 5261 |
|
|
2022
Q1 | $47K | Buy |
4,623
+474
| +11% | +$4.82K | ﹤0.01% | 5547 |
|
|
2021
Q4 | $42K | Buy |
4,149
+2,565
| +162% | +$26K | ﹤0.01% | 5984 |
|
|
2021
Q3 | $16K | Sell |
1,584
-999
| -39% | -$10.1K | ﹤0.01% | 6312 |
|
|
2021
Q2 | $26K | Sell |
2,583
-100
| -4% | -$1.01K | ﹤0.01% | 6005 |
|
|
2021
Q1 | $26K | Buy |
+2,683
| New | +$26K | ﹤0.01% | 6127 |
|